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Abstract
The DAF-2 Insulin/IGF-1 signaling (IIS) pathway is a strong modifier of Caenorhabditis elegans longevity and healthspan. As
aging is the greatest risk factor for developing neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), we
were interested in determining if DAF-2 signaling modifies disease pathology in mutant superoxide dismutase 1 (SOD1)
expressing C. elegans. Worms with pan-neuronal G85R SOD1 expression demonstrate significantly impaired locomotion as
compared to WT SOD1 expressing controls and they develop insoluble SOD1 aggregates. Reductions in DAF-2 signaling,
either through a hypomorphic allele or neuronally targeted RNAi, decreases the abundance of aggregated SOD1 and results
in improved locomotion in a DAF-16 dependant manner. These results suggest that manipulation of the DAF-2 Insulin/IGF-1
signaling pathway may have therapeutic potential for the treatment of ALS.
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Introduction
ALS is an adult onset neurodegenerative disease characterized
by progressive weakness, due to dysfunction and eventual death of
motor neurons. The majority of cases of ALS are sporadic but
single gene mutations have been described that lead to inherited
versions of the disease. These genes include SOD1, TAR DNA
binding protein (TDP43), fused in sarcoma, progranulin, ubiquilin
2 and a hexanucleotide repeat expansion of a noncoding region in
C9ORF72 [1,2,3,4,5,6,7]. Expression of some of these mutant
proteins in model organisms has been used to successfully model
ALS pathology.
Point mutations in SOD1 (e.g., G85R) are an example of a
genetic cause of familial ALS that has been successfully modeled in
transgenic mice and nematodes [8]. The G85R point mutation
causes a toxic gain-of-function, which in mice leads to ubiquiti-
nated SOD1 aggregates and motor neuron death [9]. C. elegans
expressing human G85R SOD1 in the nervous system accumulate
SOD1 aggregates and demonstrate reduced mobility compared to
WT SOD1 expressing worms [10]. The availability of numerous
loss-of-function mutants affecting highly conserved signaling
pathways make C. elegans an ideal system in which to explore the
relationship between such pathways and SOD1 aggregation and
toxicity in an in vivo setting.
Aging is the greatest risk factor for the development of ALS.
The Insulin/IGF-1 signaling (IIS) pathway is a robust modifier of
longevity and aging in C. elegans [11]. Loss of function of the
Insulin/Insulin-like growth factor receptor, DAF-2, promotes
longevity via signaling cascades mediated by inhibition of the
phosphoinositide 3-kinase (age-1) and activation of the forkhead
transcription factor DAF-16 via its nuclear localization [12].
While nuclear localization of DAF-16 is required for it to execute
its transcriptional activities, it is not sufficient to enhance
longevity and stress resistance [13]. Other pathways are known
to interact with the IIS pathway and modulate stress resistance
and/or aging by regulating transcriptional activity of DAF-16,
without modifying its nuclear abundance [14]. In addition to
promoting longevity, loss of function alleles of daf-2 or age-1
protects the worm against exogenous stressors including heat
shock, oxidative stress, heavy metal stress, UV damage and
infection [15,16,17,18]. The beneficial effects of reduced IIS rely,
in part, on the ability of decreased IIS to activate the
transcription factor DAF-16, leading to increased expression of
numerous stress resistance genes, such as small heat shock
proteins and reactive oxygen species scavenging enzymes [18,19].
Additionally, reduced IIS also results in changes in metabolism,
mitochondrial abundance and lipid biosynthesis, all of which are
thought to contribute to the stress resistant phenotype of reduced
IIS [20,21,22]. Reduced DAF-2 signaling has been shown to have
beneficial effects on other age related neurodegenerative diseases
such as polyglutamine expansion proteinopathy and Alzheimer’s
disease [12,23]. The ability to easily control the IIS pathway both
genetically and via RNA interference (RNAi) makes the worm an
excellent system for studying the interactions between aging and
the toxicity of mutant SOD1. In the present study we asked if
manipulation of IIS pathway can improve the reduced mobility
and insoluble protein aggregation seen in G85R SOD1
expressing worms.
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Decreased crawling speed of G85R worms is ameliorated
by decreased IIS signaling
We began by monitoring the average crawling speed of G85R,
G85R;daf-2(e1370), G85R;daf-16(mgDf50), daf-2(e1370) and daf-
16(mgDf50) worms on a bacterial lawn (OP50) at 96, 120, 144
and 168 hours after depositing eggs onto plates with bacteria
(figure 1 A). Group differences were observed at 96, 120 and
144 hrs post egg drop (96, 120 and 144 hrs: F(4,25)=22.96,
F(4,25)=11.08, F(4,28)=12.57 respectively by single factor ANOVA
p,0.01 at all timepoints). At 96, 120 and 144 hrs after growth
initiation, the G85R;daf-2(e1370) worms crawled approximately
twice as fast as G85R worms (p,0.05 at 96, 120 and 144 hrs by
Tukey’s post-hoc) while at the 168 hr time point no significant
difference was observed. Although not statistically significant,
G85R;daf-16(mgDf50) worms tended to perform worse than G85R
worms at all time points. These results suggest that reduced IIS
ameliorates the toxic effects of mutant SOD1, and while this
benefit is maintained for 144 hrs of life, it can not be sustained
after this point. The fact that G85R worms that are also null for
DAF-16 tend to perform worse than G85R worms suggests that
part of the worm’s endogenous response to proteotoxic insults,
such as mutant SOD1, may include activation of DAF-16.
In order to control for any potential variation in locomotion
and/or behavioral differences in worms with the daf-2(e1370) or
daf-16(mgDf50) mutations, we examined the average crawling
speed of worms carrying these mutations on a non-SOD1
background. There were no statistically significant differences
between these two groups in locomotory activity at any time point
observed (by Tukey’s post-hoc), suggesting that these mutations
are modulating the toxicity of G85R as opposed to altering other
aspects of behavior or locomotion in general.
Decreased swim speed of G85R worms is ameliorated by
decreased IIS signaling
While the crawling assay allowed us to identify an improvement
in the locomotory activity of G85R worms when they were on the
daf-2(e1370) background, the inability to control for behavior
Figure 1. A) Videos of worms crawling on OP50 at the indicated times were taken and used to calculate worm speed using the parallel worm tracker
software. B) Average swim speed normalized to size was calculated at the indicated times using the parallel worm tracker. C) Swim speed normalized
to size was calculated for TDP43 and TDP43;daf-2(e1370) worms 72 hrs post egg drop.
doi:10.1371/journal.pone.0033494.g001
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variable. In order to reduce variability we examined swimming
worms, a context which elicits continual movement.
We compared the following worm strains in the swimming assay:
WT SOD1, G85R, G85R;daf-2(e1370), G85R;daf-16(mgDf50),a n d
G85R;daf-2(e1370);daf-16(mgDf50) (figure 1 B). Between group
differences were detected at all timepoints by single factor ANOVA
(72, 96, 120, 144, and 168 hrs: F(4,25)=15.53, F(4,26)=14.22,
F(4,25)=8.67, F(4,25)=10.82, F(4,25)=9.56 p,0.01 at all timepoints).
WT SOD1 worms were significantly faster than G85R worms at all
timepoints (p,0.01 by Tukey’s post-hoc). G85R;daf-2(e1370) worms
were also significantly faster than G85R worms at all timepoints
(p,0.05 by Tukey’s post-hoc) and had mobility equivalent to WT
SOD1 worms at all time points (no significant difference by Tukey’s
post-hoc). Ablation of daf-16 in the G85R;daf-2(e1370) worms
eliminated the observed rescue effect of daf-2(e1370) as no
statistically significant difference was observed between G85R and
G85R;daf-2(e1370);daf-16(mgDf50) worms (by Tukey’s post-hoc).
These observationsprovide further data insupport of the hypothesis
that the daf-2(e1370) background is strongly protective against the
toxicityof G85R SOD1 asassessed by locomotoryfunctionand that
this protection is daf-16 dependent.
There was a trend for G85R;daf-16(mgDf50) worms to perform
worse than either G85R or (G85R;daf-2(e1370);daf-16(mgDf50)
worms although it was only significant at 96 hrs (p,0.05 by
Tukey’s post-hoc). The observation that G85R;daf-16(mgDf50)
worms tended to perform worse than G85R;daf-2(e1370);daf-
16(mgDf50) worms suggests that part of the beneficial effect of
daf-2(e1370) may be daf-16 independent. As in the crawling assay,
the fact that G85R;daf-16(mgDf50) worms tended to perform worse
than G85R worms also suggests a potential role of daf-16 in the
worm’s endogenous response to proteotoxic insults. Like the
crawling assay, the swimming assay further supports the hypothesis
that reduced IIS activity reduces G85R SOD toxicity.
In order to determine the specificity of daf-2(e1370) on SOD1
toxicity we tested the effects of daf-2(e1370) on worms expressing
TDP-43 in the nervous system (Psnb-1::hTDP-43) (Figure 1 C).
Like the mutant SOD1 expressing worms, transgenic expression of
TDP-43 in the C. elegans nervous system causes locomotory defects
and protein aggregation [24]. In a comparison of swim speed of
TDP-43 worms versus TDP-43;daf-2(e1370) worms, we found daf-
2(e1370) improved TDP-43 induced swimming deficit (p,0.01 by
t-test).
Improvement of the G85R phenotype is dependent on
decreased IIS in the nervous system
daf-2(RNAi) has previously been described to mimic the
longevity/healthspan promoting effects of the daf-2(e1370) hypo-
morphic allele and RNAi to daf-16 has been shown to abrogate the
benefits of loss of function of daf-2 [25]. We next compared
locomotion of G85R worms fed daf-2, daf-16 or empty vector (EV)
RNAi. Unexpectedly, feeding neither daf-2 nor daf-16 RNAi to
G85R worms had a significant effect on locomotion (Figure 2 D,E).
One possible explanation for these differences is the variable
effectiveness of RNAi in the worm nervous system.
The resistance of worm neurons to RNAi can be mitigated by
transgenic over expression of SID-1 in the nervous system [26].
SID-1 allows for passive cellular uptake of double stranded RNA,
therefore increasing a cells response to RNAi. SID-1 is not
normally expressed in neurons, therefore one way to selectively
increase the nervous systems response to RNAi is through
transgenic expression of SID-1 in the nervous system of worms
that are null for sid-1 in peripheral tissues. In order to maximize
the efficacy of RNAi in the nervous system of G85R worms we
generated Psnb-1::G85R::YFP; sid-1(pk3321)[Punc119::sid-1];Pmyo-
6::mcherry worms, hereafter referred to as G85R;sid-1. G85R and
G85R;sid-1 worms were fed G85R-YFP or empty vectro (EV)
RNAi. G85R;sid-1 worms fed G85R-YFP RNAi showed decrease
YFP intensity in the nervous system and a significant (p,0.05 by t-
test) increase in locomotory activity compared to G85R;sid-1
worms fed EV RNAi (Figure 2 A–B). Feeding G85R worms G85R-
YFP RNAi had no effect on fluorescence intensity or locomotory
activity (Figure 2 A and data not shown). These observations lead
to two important conclusions 1) they confirm the increased efficacy
of neuronal RNAi in the sid-1 nervous system expressing sid-
1(pk3321)[Punc119::sid-1];Pmyo-6::mcherry background and 2) dem-
onstrate that the locomotory phenotype in these worms is likely to
be due to mutant G85R SOD1 expression and not integration of
the transgene into a critical locus.
To better understand the role of IIS in the nervous system on
G85R toxicity we compared the following groups: RNAi to daf-2,
daf-16 and EV fed to G85R and G85R;sid-1 worms. While G85R
worms fed daf-2 RNAi showed no significant improvement in
mobility compared to G85R worms fed EV, G85R;sid-1 worms fed
daf-2 RNAi had significantly improved mobility compared to all
other groups (ANOVA F(3,16)=13.66 p,0.01 and p,0.01 by
Tukey’s post-hoc) (Figure 2 E). This disparity between the effects
on G85R versus G85R;sid1 worms suggests the need for decreased
IIS activity in the nervous system in this model to rescue
locomotory activity.
We also compared locomotion of G85R;daf-2(e1370) worms fed
daf-16 RNAi or EV. Feeding G85R;daf-2(e1370) worms daf-16
RNAi abrogated a significant (p,.05 by t-test) amount of the daf-
2(e1370) induced rescue of locomotory function as compared to
feeding EV RNAi (figure 2 C). It is interesting that the daf-16
(RNAi) appears to diminish daf-2(e1370) rescue on a non-
Punc119::sid1;sid1(pk3321) background suggesting it is working
outside of the nervous system. This raises the possibility that
although reduced IIS is required in the nervous system to rescue
locomotory activity in this model, there are daf-16 dependent
effects in non-nervous system tissues.
IIS activity modulates the solubility of SOD1
Aging in the worm is known to be a major modifier of
generalized protein solubility and aggregation, and decreased daf-2
signaling has been found to decrease the amount of aggregation
that occurs [27]. Since aggregated SOD1 generally correlates with
toxicity in ALS we wanted to determine if the daf-2(e1370)
background was decreasing aggregation in G85R worms. Zhang et.
al. demonstrated that the daf-2(e1370) background significantly
reduces the steady state abundance of insoluble TDP-43 in the
worms we assessed in our swimming assay [24]. To determine if
IIS was modifying the solubility of SOD1 in this model, soluble
versus insoluble fractions were prepared from G85R, G85R;daf-
2(e1370) and G85R;daf-2(e1370);daf-16(mgDf50) and immuno-
blotted for SOD1 and actin (figure 3A). We found a significant
amount of insoluble SOD1 in the G85R worms which was greatly
diminished in the daf-2(e1370) background. Deletion of daf16 in
the G85R;daf-2(e1370);daf-16(mgDf50) worms suppressed this
effect. While the absolute values of soluble SOD1 were not
constant between the three groups the ratio of insoluble to soluble
SOD1 was significantly greater in the G85R;daf-2(e1370);daf-
16(mgDf50) and G85R worms as compared to G85R;daf-2(e1370)
(figure 3B) (p,.05 by single factor ANOVA, F(2,6)=7.719 and
p,0.05 for both comparisons by Tukey’s post-hoc). This suggested
that daf-2(e1370) improves the solubility of SOD1, leading to an
increased steady-state abundance of the soluble species. These
data were collected from a mixed population of animals so we
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various ages.
Total SOD1 burden does not correlate with locomotor
activity
While no differences in YFP intensity were evident by eye when
observing the different worm strains, we wished to explore the
total burden of SOD1 at various times more closely. In order to do
this we used the COPAS worm sorter to measure YFP intensity
and time-of-flight (TOF, i.e., length) in individual animals from a
mixed population of approximately ten thousand worms from the
following groups: G85R, G85R;daf-2(e1370) and G85R;daf-
2(e1370);daf-16(mgDf50) (figure 3C). Using TOF as a proxy for
age, we were unable to identify a direct correlation between total
SOD1 burden and locomotory activity. The data were binned into
TOF measurements of 100 units and significant differences
between groups were observed in all bins by ANOVA (0–100
TOF F(2,11369)=881.69, 101–200 TOF F(2,7209)=250.90, 201–
300 TOF F(2,4880)=48.1, 301–400 TOF F(2,3075)=243.23, 401–
500 TOF F(2,1435)=411.05, 501–600 TOF F(2,708)=277.65). In
Figure 2. A) YFP signal was imaged in G85R or G85R;unc119p::sid1;sid1(pk3321) worms fed empty vector (EV) or G85R:YFP RNAi in order to
demonstrate the efficacy of RNAi in neurons on the unc119p::sid1;sid1(pk3321) background B–E) Average speed normalized to size of swimming
worms fed bacteria expressing the indicated RNAi.
doi:10.1371/journal.pone.0033494.g002
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between G85R and G85R;daf-2(e1370) worms (no significant
differences between groups by Scheffe’s post-hoc), yet significant
locomotory differences were observed between these groups at all
ages assessed using the swimming assay. Conversely, young
G85R;daf-2(e1370);daf-16(mgDf50) worms have significantly less
YFP intensity than G85R and G85R;daf-2(e1370) worms (p,0.05
by Scheffe’s post-hoc), yet they perform worse than G85R;daf-
2(e1370) worms and equivalent to G85R worms in our locomotory
assays. Looking at older worms (300–600 TOF), G85R worms
have a total SOD1 burden that significantly exceeds that of
G85R;daf-2(e1370);daf-16(mgDf50) worms (p,0.05 by Scheffe’s
post-hoc in 301–400, 401–500 and 501–600 bins) yet they show
similar locomotory activity in the swim test. This is unlikely to
simply be a floor-type effect as G85R;daf-16(mgDf50) worms
perform worse in the swimming assay than both G85R and
G85R;daf-2(e1370);daf-16(mgDf50) worms, suggesting that there is
room for decline in the locomotory phenotype. Taken together
these results suggest that overall SOD1 burden is not responsible
for the locomotory differences observed between these groups, but
rather suggest that the locomotory differences result from changes
in how SOD1 toxicity is handled in these various backgrounds.
IIS effects on longevity in the SOD1 background
The toxicity of mutant SOD1 expression in the C. elegans
nervous system was previously reported to have a negative effect
on lifespan [10]. In order to determine whether decreased daf-2
signaling in this background has a beneficial effect on lifespan,
similar to its effect on locomotion, longevity was monitored in WT
SOD1, G85R;daf-2(e1370) and G85R;daf-2(e1370);daf-16(mgDf50)
worms (figure 4). WT SOD1 and G85R;daf-2(e1370);daf-16(mgDf50)
worms had similar lifespans, while the G85R;daf-2(e1370) worms
had a modest but statistically significant increase in lifespan
(p,0.05 by Mann-Whitney analysis). Interestingly, there is no
correlation between health and lifespan as assayed by locomotory
activity.
Discussion
Aging is a common risk factor for many neurodegenerative
diseases [28]. The IIS pathway is a well characterized genetic
modifier of aging in C. elegans [11] and we demonstrate here that
alterations in this pathway can robustly modify the toxicity of
mutant SOD1 as assessed by mobility, protein aggregation and
longevity. We find that reduced daf-2 activity has a beneficial effect
on the toxicity of G85R SOD1 and that this beneficial effect is daf-
16 dependent. While aging in the worm has previously been
shown to be coordinated at the organismal level, we found a
requirement for IIS to be reduced in the nervous system in order
to modify SOD1 toxicity. Although the genetic modifiers of aging
are less well characterized in humans, these data suggest that IIS
and pathways which beneficially modify lifespan/healthspan in
humans may be potential targets for therapeutic intervention in
ALS.
Figure 3. A) Representative western blot from three experiments looking at soluble vs insoluble SOD1 B) Quantification of SOD1 insoluble : soluble
ratio C) COPAS data showing average YFP intensity for bins of various worm TOF.
doi:10.1371/journal.pone.0033494.g003
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understood, aggregated proteins are associated with numerous
neurodegenerative diseases, including ALS [29,30]. As aging
occurs, the total burden of aggregated proteins increases,
suggesting a diminished capacity for proper folding and/or
degradation of aggregation prone proteins with age [31]. In this
study we demonstrate that a LOF mutation of daf-2 diminishes the
amount of insoluble SOD1; an effect that might be due to an
increased capacity for clearance/folding in these worms. Similar
observations have been made regarding the ability of modifica-
tions of IIS to modulate the solubility and toxicity of other disease
related proteins [12,24,32]. This is likely due to the ability of
decreased IIS to induce expression of chaperones such as the HSP
family of proteins [19]. An RNAi screen performed on these
worms identified chaperones as the most highly represented
functional class of proteins found to negatively modify SOD1
aggregation in this model [10]. Increased capacity for folding/
clearance in worms with reduced IIS is likely to contribute to
decreasing the toxcicity of mutant SOD1 in this model. We can
not rule out the contribution of other changes in metabolism, lipid
biogenesis, and free radical scavenger expression which have also
been linked to increased lifespan and stress resistance due to
decreased IIS [18,21,22].
Our data from the COPAS support both the concept that: 1) the
daf-2(e1370) background can help reduce buildup of insoluble
protein and 2) the ratio of soluble to insoluble G85R SOD1, rather
than its total abundance, is associated with toxicity in this model.
Using TOF as an approximation for age, it appears that G85R
worms accumulate less G85R SOD1 on the daf-2(e1370) as
opposed to wild type background over time. This suggests an
increased capacity for clearance of SOD1 over time in the daf-
2(e1370) background. The abundance of SOD1 in G85R;daf-
2(e1370);daf-16(mgDf50) worms is less than both G85R and
G85R;daf-2(e1370) in young animals yet their mobility is reduced
compared to G85R;daf-2(e1370) and equivalent to G85R at all time
points assessed. Although the relative abundance of SOD1 varies
between these strains over time, their relative locomotory activity
remains constant, suggesting that it is not total SOD1 abundance
that dictates toxicity.
Previous work with a worm model of Ab toxicity has
demonstrated that the daf-2(e1370) allele is protective against
Ab1–42 aggregates in two distinct ways. First daf-2(e1370) led to
activation of hsf-1 which resulted in breakdown of Ab1–42 fibrils.
Second daf-2(e1370) led to activation of daf-16 which increased the
abundance of Ab1–42 in high molecular weight aggregates. It is
possible that both activities diminish Ab1–42 toxicity by removing
Ab1–42from the putatively toxic fibril pool [23]. If these
observations can be generalized, they could account for the lack
of correlation between total SOD1 abundance and locomotory
deficits in these worms. G85R;daf-2(e1370);daf-16(mgDf50) worms
may not show the robust increase in SOD1 over time seen in the
G85R worms because they are not accumulating the large
aggregates of protein. These worms still suffer from SOD1 toxicity
due to high levels of insoluble SOD1, but may never reach the
same YFP intensity as G85R worms due to a lack of high molecular
weight aggregation facilitated by daf-16. Activation of hsf-1 in the
G85R;daf-2(e1370);daf-16(mgDf50) worms may also explain their
increased mobility compared to G85R;daf-16(mgDf50) worms in
the motility assay.
Using worms with neuronal expression of SID1, we demon-
strate that the beneficial effect of reduced daf-2 is likely to be
mediated by decreased IIS signaling in the nervous system. This
contrasts with its effects on longevity, where daf-2 RNAi (on a
background lacking pk3321 to enhance neuronal RNAi) mimics
the lifespan extending effects of the daf-2(e1370) allele. In this
setting, daf-2 RNAi does not influence gene expression in the
nervous system [33]. G85R;daf-2(e1370) worms fed daf-16 RNAi
should have normal levels of DAF-16 in their nervous system and
it would be activated due to the daf-2(e1370) background. If the
beneficial effect of decreased daf-2 activity was completely
mediated by the nervous system, then these worms should have
comparable locomotory function to G85R;daf-2(e1370) worms fed
empty vector. We find these worms to have an intermediate
phenotype with a significant reduction in locomotory activity as
compared to worms on empty vector RNAi plates. This suggests
that part of the beneficial effect of daf-2(e1370) might be mediated
through non-neuronal tissue(s). Alternatively, daf-16(RNAi) may
partially, although not completely, reduce daf-16 expression in
both neuronal and non-neuronal cells. Taken together, these
findings suggest that although decreased IIS is required in the in
the nervous system in order to have a beneficial effect on SOD1
toxicity, some of the downstream actions of reduced neuronal IIS
may be functioning in the periphery.
Our results demonstrate the strong capacity of the IIS pathway
to modulate G85R proteotoxicity. One possible mechanism of
action for this beneficial effect is through the ability of this pathway
to increase the cellular capacity to prevent toxic insoluble protein
accumulation. Interestingly this beneficial activity of IIS may not
be completely cell autonomous but may be in part a manifestation
of alterations in cellular aging coordinated at the organismal level.
This pathway may represent a possible therapeutic target for
proteotoxic diseases cause by insoluble proteins.
Figure 4. Longevity analysis, percent alive per day.
doi:10.1371/journal.pone.0033494.g004
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Worm Strains and Handling
C. elegans were cultured under standard conditions at 20uC and
fed the E. coli strain OP50 [34]. The following worm strains were
used: daf-16(mgDf50) and daf-2(e1370) were obtained from the
CGC. Psnb-1::hTDP-43;Pmtl-2::GFP and daf-2(e1370); Psnb-
1::hTDP-43;Pmtl-2::GFP were a generous gift of Chris Link. Psnb-
1::G85R SOD1::YFP and Psnb-1::WT SOD1::YFP were a generous
gift from Arthur Horwich and Jiou Wang. Punc119::sid1;-
sid1(pk3321) was a generous gift from Martin Chalfie. Double
and triple worms were generated by standard genetic crosses and
verified by PCR or fluorescence expression.
Locomotory Assay
Video recordings of worms were made using the image
acquisition tool in Matlab 2009b. These videos were then analyzed
using the parallel worm tracker software (downloaded from the
Goodman lab http://wormsense.stanford.edu/tracker/). For
monitoring locomotion on OP50 a 1 minute video was recorded
from each plate at the center of the lawn of OP50. At 50 worms
were analyzed for each genotype at each timepoint. The number
of worms was greater than 30 for each genotype at each timepoint.
For the swimming assay worms were suspended in a pool of M9
and their swimming was recorded for 30 seconds. At least 30
worms were analyzed per group per timepoint. Statistics were
performed using the average of each video as an n of 1 for speed or
size/speed.
Feeding RNAi
HT115 bacteria containing the indicated genes in the L4440
vector were grown overnight at 37uC in 50 ug/ml ampicillin.
They were then seeded on to NGM plates supplemented with
12.5 ug/ml tetracycline and 4 mM IPTG and allowed to grow
overnight at room temperature. Gravid adults were allowed to
drop eggs on the RNAi plates for 2 hrs and were then removed.
Plates were then kept at 20uC until they were assayed.
Imaging
Worms were immobilized in 25 mM levamisole on agar pad
slides and then coverslipped. Images were acquired at a constant
intensity on a confocal microscope using a 40 uM Zstack.
Soluble vs Insoluble Protein Assay
Approximately 100 ul of packed worms were lysed via
sonication in 300 ul RIPA buffer (150 mM NaCl, 50 mM Tris
pH 8.0, 1 mM EGTA, 5 mM EDTA, 1% NP40, 0.5% Sodium
Deoxycholate, 0.1% SDS) with complete protease inhibitor
cocktail. A soft spin of 800 g for 5 min was performed to remove
unlysed worms and large debris from the lysate. The supernatant
was then spun at 99,0006g for 30 min @ 4uC. The supernatant
was kept as the soluble fraction. The pellet was sonicated again in
RIPA as a wash step to ensure removal of all soluble protein. It
was centrifuged again at 99,0006g for 30 min @ 4uC. The pellet
was then solublized in 50 ul urea buffer (40 mM Tris, 7 M urea,
2 M thiourea, 1% CHAPS). Equal volumes of sample were run on
SDS-page gels under reducing conditions and probed with anti
SOD1 antibody (Cell Signaling #2770) and anti actin (Sigma).
Westerns were visualized using the Odyssey system and quantified
using ImageJ.
COPAS
COPAS was used to sort and collect fluorescence intensity from
10,000 worms from each group as described in [35].
Longevity Assay
An egg drop was performed on NGM plates with OP50. The
lifespan assay was carried out at 20uC and worms were transferred
to fresh NGM OP50 plates as necessary in order to avoid starving
the animals. Each day worms were counted. FUDR was not
included in this assay so during the active reproductive period of
the worms they were transferred to a new plate each day.
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